GMI Thrombectomy Devices Market | страница 2

https://www.gminsights.com/industry-analysis/thrombectomy-devices-market Ambulatory surgical centers are the most lucrative end use segment. Growing number of surgeries performed with image-guided, presence of favorable reimbursement for thrombectomy procedures, technological advancement in minimally invasive surgical methods and growing need for miniaturized therapeutic devices will expand the business over the forecast period. U.S. thrombectomy devices market size should witness significant growth over the forecast period. The growth is attributed to increased acceptance of technologically advanced devices, presence of favorable medical reimbursement and rising clinical trials. The American Association of Heart Failure Nurses (AAHFN) is an organization involved in the advancement of clinical practice, research, and nursing education for the recovery of heart failure patient better outcomes. The association unites caregivers, professionals, and patients to support and improve practice of heart failure. Germany should experience significant growth over the forecast period. The German Society for Muscular Dystrophy Association (DGM) funds research for the treatment of neuromuscular diseases. It is the largest self-help Muscular Dystrophy organization in the country. India should experience lucrative growth over the forecast period. Increasing R&D and geriatric population base coupled with prevalence of chronic diseases and peripheral arterial diseases (PAD) should drive thrombectomy devices market size over the forecast period. Companies operating in thrombectomy devices market include Boston Scientific, The Spectranetics, Medtronic, Teleflex, Penumbra, AngioDynamics, Terumo, Johnson and Johnson, Stryker and Vascular Solutions. Companies are focusing on new product launch and mergers & acquisitions as their major strategies to gain revenue share in the coming years. In July 2016, Penumbra launched ACE 68 Reperfusion Catheter thrombectomy device in the U.S. for its commercial use. The catheter uses the current advancements available in the tracking technology and offer maximum aspiration power to extract thrombus in stroke patient. This should strengthen the product portfolio of Penumbra. . About Global Market Insights: Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology. 2 | Page